Investing Profile

David Parkinson

Advisor
President & Chief Executive Officer at ESSA Pharma
South San Francisco, California
Photo of David Parkinson, ESSA Pharma

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
NewCo Network
1599 CONNECTIONS
NewCo Network
1599 CONNECTIONS
Top-Patents Network
1033 CONNECTIONS
Top-Patents Network
1033 CONNECTIONS
University of Toronto Network
83 CONNECTIONS
cb
5
CompanyStageDateRound SizeTotal Raised
Mersana Therapeutics
Series CJun 2016$33M
Series BMar 2015$35M
Series AApr 2014$15M
Series AJul 2012$27M
$110M
Co-investors: Sara Nayeem (Avoro Ventures), Elliott Sigal
Zyngenia
Series ASep 2010$25M
$25M
Director, Board of Directors Biogen IdecPresent
Senior Vice President NewCoPresent
Director, Board of Directors NewCoPresent
Senior Vice President Top-PatentsPresent
President & Chief Executive Officer NodalityPresent
Director, Board of Directors Top-PatentsPresent
Chief, Investigational Drug Branch IDB; Acting Associate Director, CTEP National Cancer Institute (NCI)Present
Vice President, Oncology Clinical Development NovartisPresent
Vice President, Oncology Research and Development AmgenPresent
Senior Vice President Biogen IdecPresent
President & Chief Executive Officer Nodality Inc.Present
Director, Board of Directors TocagenPresent
Director, Board of Directors 3SBio Inc.Present
Director, Board Of Directors CTI BioPharmaPresent
Chairman of the Board & Scientific Co-Founder Refuge BiotechnologiesPresent
President & Chief Executive Officer ESSA PharmaPresent
Venture Partner New Enterprise Associates (NEA)2012 - 2016
University of Toronto MD Medicine